BR112013020648B1 - sistema e método para processar microesferas usando um hidrociclone - Google Patents
sistema e método para processar microesferas usando um hidrociclone Download PDFInfo
- Publication number
- BR112013020648B1 BR112013020648B1 BR112013020648A BR112013020648A BR112013020648B1 BR 112013020648 B1 BR112013020648 B1 BR 112013020648B1 BR 112013020648 A BR112013020648 A BR 112013020648A BR 112013020648 A BR112013020648 A BR 112013020648A BR 112013020648 B1 BR112013020648 B1 BR 112013020648B1
- Authority
- BR
- Brazil
- Prior art keywords
- suspension
- microspheres
- fluid
- fluid outlet
- inlet
- Prior art date
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 198
- 238000000034 method Methods 0.000 title claims abstract description 68
- 238000012545 processing Methods 0.000 title claims abstract description 27
- 239000000725 suspension Substances 0.000 claims abstract description 219
- 239000012530 fluid Substances 0.000 claims abstract description 146
- 238000004891 communication Methods 0.000 claims abstract description 18
- 239000012510 hollow fiber Substances 0.000 claims description 43
- 239000002904 solvent Substances 0.000 claims description 40
- 230000001186 cumulative effect Effects 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 230000003134 recirculating effect Effects 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 abstract description 14
- 239000013543 active substance Substances 0.000 abstract description 13
- 239000007788 liquid Substances 0.000 abstract description 12
- 239000002245 particle Substances 0.000 description 106
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 53
- 239000012071 phase Substances 0.000 description 43
- 230000008569 process Effects 0.000 description 32
- 239000003814 drug Substances 0.000 description 27
- 229940079593 drug Drugs 0.000 description 27
- 239000003085 diluting agent Substances 0.000 description 19
- 229960003722 doxycycline Drugs 0.000 description 17
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 238000009826 distribution Methods 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 238000001914 filtration Methods 0.000 description 12
- JYVNDCLJHKQUHE-UHFFFAOYSA-N hydroxymethyl acetate Chemical compound CC(=O)OCO JYVNDCLJHKQUHE-UHFFFAOYSA-N 0.000 description 12
- 238000009472 formulation Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000011859 microparticle Substances 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000012466 permeate Substances 0.000 description 7
- 238000013268 sustained release Methods 0.000 description 7
- 239000012730 sustained-release form Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000012447 hatching Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 3
- 229920001515 polyalkylene glycol Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000013557 residual solvent Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013020 final formulation Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100030500 Heparin cofactor 2 Human genes 0.000 description 1
- 101710153650 Heparin cofactor 2 Proteins 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000005112 continuous flow technique Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- -1 fatty acid esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
- 229940045946 sodium taurodeoxycholate Drugs 0.000 description 1
- YXHRQQJFKOHLAP-FVCKGWAHSA-M sodium;2-[[(4r)-4-[(3r,5r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 YXHRQQJFKOHLAP-FVCKGWAHSA-M 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004546 suspension concentrate Substances 0.000 description 1
- 210000005222 synovial tissue Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04F—PUMPING OF FLUID BY DIRECT CONTACT OF ANOTHER FLUID OR BY USING INERTIA OF FLUID TO BE PUMPED; SIPHONS
- F04F5/00—Jet pumps, i.e. devices in which flow is induced by pressure drop caused by velocity of another fluid flow
- F04F5/44—Component parts, details, or accessories not provided for in, or of interest apart from, groups F04F5/02 - F04F5/42
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/12—Machines, pumps, or pumping installations having flexible working members having peristaltic action
Landscapes
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- Fluid Mechanics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Separation Of Solids By Using Liquids Or Pneumatic Power (AREA)
- Cyclones (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/028,764 US8708159B2 (en) | 2011-02-16 | 2011-02-16 | Manufacture of microspheres using a hydrocyclone |
| PCT/US2012/025378 WO2012112747A2 (en) | 2011-02-16 | 2012-02-16 | Manufacture of microspheres using a hydrocyclone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112013020648A2 BR112013020648A2 (pt) | 2016-10-18 |
| BR112013020648B1 true BR112013020648B1 (pt) | 2019-09-03 |
Family
ID=46636079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013020648A BR112013020648B1 (pt) | 2011-02-16 | 2012-02-16 | sistema e método para processar microesferas usando um hidrociclone |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8708159B2 (enExample) |
| EP (1) | EP2675559B1 (enExample) |
| JP (2) | JP6180327B2 (enExample) |
| CN (1) | CN103732318B (enExample) |
| AU (1) | AU2012217620B2 (enExample) |
| BR (1) | BR112013020648B1 (enExample) |
| ES (1) | ES2807350T3 (enExample) |
| MX (1) | MX2013009056A (enExample) |
| WO (1) | WO2012112747A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10188119B2 (en) | 2001-07-16 | 2019-01-29 | Foret Plasma Labs, Llc | Method for treating a substance with wave energy from plasma and an electrical arc |
| US8764978B2 (en) | 2001-07-16 | 2014-07-01 | Foret Plasma Labs, Llc | System for treating a substance with wave energy from an electrical arc and a second source |
| CA2683165C (en) | 2006-04-05 | 2013-06-11 | Foret Plasma Labs, Llc | System, method and apparatus for treating liquids with wave energy from plasma |
| US9185787B2 (en) | 2007-10-16 | 2015-11-10 | Foret Plasma Labs, Llc | High temperature electrolysis glow discharge device |
| US9761413B2 (en) | 2007-10-16 | 2017-09-12 | Foret Plasma Labs, Llc | High temperature electrolysis glow discharge device |
| US9516736B2 (en) | 2007-10-16 | 2016-12-06 | Foret Plasma Labs, Llc | System, method and apparatus for recovering mining fluids from mining byproducts |
| US10267106B2 (en) | 2007-10-16 | 2019-04-23 | Foret Plasma Labs, Llc | System, method and apparatus for treating mining byproducts |
| US9051820B2 (en) | 2007-10-16 | 2015-06-09 | Foret Plasma Labs, Llc | System, method and apparatus for creating an electrical glow discharge |
| US9560731B2 (en) | 2007-10-16 | 2017-01-31 | Foret Plasma Labs, Llc | System, method and apparatus for an inductively coupled plasma Arc Whirl filter press |
| US11806686B2 (en) | 2007-10-16 | 2023-11-07 | Foret Plasma Labs, Llc | System, method and apparatus for creating an electrical glow discharge |
| US9230777B2 (en) | 2007-10-16 | 2016-01-05 | Foret Plasma Labs, Llc | Water/wastewater recycle and reuse with plasma, activated carbon and energy system |
| US8278810B2 (en) | 2007-10-16 | 2012-10-02 | Foret Plasma Labs, Llc | Solid oxide high temperature electrolysis glow discharge cell |
| MX2010008819A (es) | 2008-02-12 | 2010-11-05 | Foret Plasma Labs Llc | Metodo, sistema y aparato para combustion con escaso combustible con plasma de arco electrico. |
| US8904749B2 (en) | 2008-02-12 | 2014-12-09 | Foret Plasma Labs, Llc | Inductively coupled plasma arc device |
| US10244614B2 (en) | 2008-02-12 | 2019-03-26 | Foret Plasma Labs, Llc | System, method and apparatus for plasma arc welding ceramics and sapphire |
| US8708159B2 (en) * | 2011-02-16 | 2014-04-29 | Oakwood Laboratories, Llc | Manufacture of microspheres using a hydrocyclone |
| MX379490B (es) * | 2012-12-11 | 2025-03-10 | Foret Plasma Labs Llc | Sistema de reactor de vortice a contracorriente a alta temperatura, metodo y aparato. |
| EP2971488B1 (en) | 2013-03-12 | 2018-09-26 | Foret Plasma Labs, Llc | Apparatus and method for sintering proppants |
| WO2014144309A1 (en) * | 2013-03-15 | 2014-09-18 | Oakwood Laboratories | Sustained release microspheres and method of producing the same |
| EP3784705A4 (en) * | 2018-04-23 | 2022-03-02 | Graybug Vision, Inc. | IMPROVED CONTINUOUS PRODUCTION OF MICROPARTICLES |
| DE102018207441B4 (de) * | 2018-05-15 | 2022-08-18 | Bayerische Motoren Werke Aktiengesellschaft | Verfahren zum Analysieren der in einem Betriebsfluid einer Vorrichtung enthaltenen Partikel sowie Vorrichtung zum Durchführen des Verfahrens |
| JP7157263B2 (ja) * | 2019-07-01 | 2022-10-19 | オークウッド ラボラトリーズ，エル．エル．シー． | ミクロスフェア及びエマルションを製造するためのシステム及び方法 |
| CN112494456B (zh) * | 2020-12-16 | 2022-05-03 | 西南石油大学 | 一种乙基纤维素中空微囊 |
| EP4598504A2 (en) | 2022-10-05 | 2025-08-13 | Mireca Medicines GmbH | Microparticle and implant formulations for cgmp analog therapy |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3869559A (en) * | 1970-04-13 | 1975-03-04 | Thomas P Clark | Process for separation and cleaning of edible vegetable products |
| FR2381896A1 (fr) * | 1977-02-24 | 1978-09-22 | Elf Aquitaine | Recuperation des fluides de forage |
| US4279743A (en) * | 1979-11-15 | 1981-07-21 | University Of Utah | Air-sparged hydrocyclone and method |
| US4810264A (en) * | 1984-02-23 | 1989-03-07 | Shell Oil Company | Process for cleaning and splitting particle-containing fluid with an adjustable cyclone separator |
| GB9221329D0 (en) * | 1992-10-10 | 1992-11-25 | Delta Biotechnology Ltd | Preparation of further diagnostic agents |
| US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| GB9513659D0 (en) * | 1995-07-05 | 1995-09-06 | Advanced Assured Homes 17 Plc | Improvements in or relating to ultrasonic processors |
| JP3969771B2 (ja) * | 1996-10-29 | 2007-09-05 | 英人 吉田 | 液体サイクロンおよび液体サイクロンを用いた分離方法 |
| US5945126A (en) | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
| US6270802B1 (en) | 1998-10-28 | 2001-08-07 | Oakwood Laboratories L.L.C. | Method and apparatus for formulating microspheres and microcapsules |
| US6705757B2 (en) | 1999-11-12 | 2004-03-16 | Alkermes Controlled Therapeutics, Inc. Ii | Method and apparatus for preparing microparticles using in-line solvent extraction |
| JP4287613B2 (ja) * | 2000-04-28 | 2009-07-01 | 田辺三菱製薬株式会社 | マイクロスフェアの製法 |
| FR2815540B1 (fr) | 2000-10-19 | 2005-06-10 | Separex Sa | Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote |
| IT1319693B1 (it) * | 2000-12-15 | 2003-10-23 | Eni Spa | Procedimento per la separazione di microsfere di vetro cave da fanghiche le contengono. |
| GB0219815D0 (en) * | 2002-08-24 | 2002-10-02 | Accentus Plc | Preparation of small crystals |
| WO2004009200A2 (en) * | 2002-07-22 | 2004-01-29 | Mba Polymers, Inc. | Controlling media particle size in slurried dense media separations |
| JP2004053552A (ja) * | 2002-07-24 | 2004-02-19 | Toray Ind Inc | 液体流通装置内の液体流動状態の非破壊検査方法 |
| US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
| US6892887B2 (en) * | 2003-02-10 | 2005-05-17 | Alpine Mud Products Corp | Polymer drilling bead recovery system and related methods |
| US6902593B2 (en) * | 2003-02-26 | 2005-06-07 | Kellogg Brown And Root, Inc. | Separation device to remove fine particles |
| JP2005227429A (ja) * | 2004-02-12 | 2005-08-25 | Fuji Photo Film Co Ltd | 写真廃液の処理装置及び方法 |
| US20090104274A1 (en) * | 2005-03-01 | 2009-04-23 | Ajay Khopade | Process of making microspheres |
| US7438142B2 (en) * | 2006-03-23 | 2008-10-21 | M-I Llc | Recovery system |
| US7520342B2 (en) * | 2006-03-23 | 2009-04-21 | M-I L.L.C. | Recovery system |
| EP1920765A1 (en) * | 2006-11-07 | 2008-05-14 | Medigene AG | Liposome preparation by single-pass process |
| US20130045393A1 (en) * | 2007-07-12 | 2013-02-21 | Dsm Ip Assets B.V. | Organic nano-particles and process for their preparation |
| CA2692892A1 (en) * | 2007-07-24 | 2009-01-29 | Michael Malakhov | Technology for the preparation of microparticles |
| KR100917185B1 (ko) | 2007-11-13 | 2009-09-15 | (주)아모레퍼시픽 | 고분자 입자제조장치, 고분자입자 제조방법 및 이 방법에의해 제조된 고분자 입자를 포함하는 조성물 |
| JP5757872B2 (ja) * | 2008-09-11 | 2015-08-05 | エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ | 調整可能な抽出速度を有する溶媒抽出マイクロカプセル化 |
| CN101502818A (zh) * | 2009-03-05 | 2009-08-12 | 煤炭科学研究总院唐山研究院 | 一种粗煤泥水力分级分选一体化装置及分级分选系统 |
| KR100924236B1 (ko) | 2009-06-23 | 2009-10-29 | 충남대학교산학협력단 | 균일한 입도분포를 가지는 초미세입자의 신규한 제조방법 및 장치 |
| US8708159B2 (en) * | 2011-02-16 | 2014-04-29 | Oakwood Laboratories, Llc | Manufacture of microspheres using a hydrocyclone |
-
2011
- 2011-02-16 US US13/028,764 patent/US8708159B2/en active Active
-
2012
- 2012-02-16 ES ES12747099T patent/ES2807350T3/es active Active
- 2012-02-16 AU AU2012217620A patent/AU2012217620B2/en active Active
- 2012-02-16 BR BR112013020648A patent/BR112013020648B1/pt active IP Right Grant
- 2012-02-16 EP EP12747099.5A patent/EP2675559B1/en active Active
- 2012-02-16 JP JP2013554593A patent/JP6180327B2/ja active Active
- 2012-02-16 CN CN201280009305.8A patent/CN103732318B/zh active Active
- 2012-02-16 WO PCT/US2012/025378 patent/WO2012112747A2/en not_active Ceased
- 2012-02-16 MX MX2013009056A patent/MX2013009056A/es active IP Right Grant
-
2017
- 2017-03-06 JP JP2017041674A patent/JP6359138B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2675559B1 (en) | 2020-06-10 |
| CN103732318A (zh) | 2014-04-16 |
| JP6180327B2 (ja) | 2017-08-16 |
| EP2675559A4 (en) | 2018-01-24 |
| ES2807350T3 (es) | 2021-02-22 |
| WO2012112747A2 (en) | 2012-08-23 |
| BR112013020648A2 (pt) | 2016-10-18 |
| JP2017148800A (ja) | 2017-08-31 |
| JP6359138B2 (ja) | 2018-07-18 |
| WO2012112747A3 (en) | 2012-11-15 |
| US20120205293A1 (en) | 2012-08-16 |
| AU2012217620A1 (en) | 2013-08-29 |
| AU2012217620B2 (en) | 2016-11-17 |
| US8708159B2 (en) | 2014-04-29 |
| JP2014511265A (ja) | 2014-05-15 |
| CN103732318B (zh) | 2016-04-13 |
| MX2013009056A (es) | 2013-12-02 |
| EP2675559A2 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013020648B1 (pt) | sistema e método para processar microesferas usando um hidrociclone | |
| Duarte et al. | Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques | |
| US9248584B2 (en) | High-temperature spray drying process and apparatus | |
| US7087245B2 (en) | ICAM-1 formulation having controlled-size microparticles | |
| US20170333861A1 (en) | Spray-drying process | |
| JP6192649B2 (ja) | 懸濁液から固形物を濾過し乾燥させ収容するための装置 | |
| PT106237A (pt) | Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas | |
| CN102970978A (zh) | 活性药物成分的颗粒加工方法 | |
| PT1440082E (pt) | Processamento de fluidos supercríticos: preparação de micropartículas de proteína e sua estabilização | |
| JP6949488B2 (ja) | 超音波前駆体の調製方法 | |
| JP6555725B2 (ja) | 生分解性微粒子からの溶媒抽出 | |
| CN105796492B (zh) | 利伐沙班纳米混悬剂及其制备方法 | |
| RU2590693C1 (ru) | Способ получения нанокапсул адаптогенов в пектине | |
| CN106361724B (zh) | 一种20(R)-人参皂苷Rg3缓释纳米微球组合及其制备方法 | |
| CN106344508A (zh) | 一种莪术醇纳米混悬剂及其制备方法和应用 | |
| Elizondo et al. | Preparation of biodegradable poly (methyl vinyl ether-co-maleic anhydride) nanostructured microparticles by precipitation with a compressed antisolvent | |
| Carr et al. | Particle formation of budesonide from alcohol-modified subcritical water solutions | |
| CN103263385A (zh) | 一种塞来昔布长效纳米注射剂及其制备方法 | |
| US8207236B2 (en) | Method for the production of porous particles | |
| Xie et al. | Recent progress of supercritical carbon dioxide in producing natural nanomaterials | |
| CN105919975A (zh) | 一种莽草酸核壳结构纳米制剂及其制备方法 | |
| CN106890145A (zh) | 一种难溶性药物纳米晶体及其制备方法和应用 | |
| CN113057943A (zh) | 一种二丙酸倍他米松纳米冻干粉针剂及其制备方法 | |
| RU2622752C1 (ru) | Способ получения нанокапсул сухого экстракта шпината | |
| RU2632428C1 (ru) | Способ получения нанокапсул сухого экстракта топинамбура в ксантановой камеди |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/02/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/02/2012, OBSERVADAS AS CONDICOES LEGAIS |